Fed governors may dissent against Powell amid Trump pressure - WSJ’s Timiraos
Investing.com-- Shares of U.S. medical device companies climbed sharply on Tuesday, boosted by Health Secretary Robert F. Kennedy Jr.’s strong endorsement of wearables during congressional testimony.
Kennedy announced a new “Make America Healthy Again” campaign, expressing his goal that "every American is wearing a wearable within four years", citing low-cost health tracking as a preferable alternative to expensive treatments like Ozempic .
DexCom Inc (NASDAQ:DXCM) led gains, with its stock jumping nearly 10%, outperforming both the broader market and rivals.
Abbott Laboratories (NYSE:ABT), a major maker of glucose‑monitoring devices, rose about 4%, while Insulet Corporation (NASDAQ:PODD) shares jumped 4.5% in extended trading.
Kennedy’s remarks come amid a surge in consumer and investor enthusiasm for wearables and fitness trackers.